Free. Unsubscribe any time.
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. filed 7 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 7 transactions and 68,156 shares. None carries the SEC's AFF10B5ONE flag; all 7 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-06-23, came on the same day as the one before it (2026-06-23) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 465 shares, 823 fewer than the 1,288 in the filing before it.
- Its 7 filings on file run from 2026-06-23 to 2026-06-23, and state 3 plan adoption dates, from 2026-02-25 to 2026-02-28.
Trades in CRESCENT BIOPHARMA, INC. 7
- Bispham Barbara Harlin — 2026-06-22 · S · 1,218 shares
- Brumm Joshua T — 2026-06-22 · S · 42,305 shares
- Im Ellie Eunkyung — 2026-06-22 · S · 1,219 shares
- Lynch Ryan — 2026-06-22 · S · 465 shares
- McNeill Jonathan — 2026-06-22 · S · 20,549 shares
- Pinkas Jan — 2026-06-22 · S · 1,288 shares
- Scalzo Richard William — 2026-06-22 · S · 1,112 shares
Adoption dates in CRESCENT BIOPHARMA, INC. 3
- 2026-02-25 — stated in 5 filings
- 2026-02-26 — stated in 1 filing
- 2026-02-28 — stated in 1 filing
Results prints in CRESCENT BIOPHARMA, INC. 0
Trades before a print in CRESCENT BIOPHARMA, INC. 0
Interval to CRESCENT BIOPHARMA, INC.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 7no later print
Adoption dates CRESCENT BIOPHARMA, INC. states
- 2026-02-25 in 5 filings
- 2026-02-26 in 1 filing
- 2026-02-28 in 1 filing
Filing text: “10b5-1 instruction adopted by the reporting person on February 28, 2026”
Sources: SEC EDGAR full-text search and the SEC submissions API.